Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC daily Stock Chart
AstraZeneca PLC
Index- P/E36.63 EPS (ttm)1.07 Insider Own0.50% Shs Outstand2.53B Perf Week2.09%
Market Cap98.74B Forward P/E20.79 EPS next Y1.88 Insider Trans0.00% Shs Float2.53B Perf Month4.05%
Income2.71B PEG2.93 EPS next Q0.45 Inst Own17.00% Short Float0.57% Perf Quarter4.69%
Sales22.34B P/S4.42 EPS this Y-13.40% Inst Trans-0.07% Short Ratio3.56 Perf Half Y8.62%
Book/sh4.99 P/B7.83 EPS next Y11.64% ROA4.20% Target Price41.66 Perf Year12.78%
Cash/sh1.49 P/C26.14 EPS next 5Y12.50% ROE19.70% 52W Range31.99 - 40.16 Perf YTD12.62%
Dividend1.40 P/FCF- EPS past 5Y-13.50% ROI13.30% 52W High-2.69% Beta0.60
Dividend %3.58% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin80.00% 52W Low22.16% ATR0.63
Employees61100 Current Ratio0.70 Sales Q/Q2.10% Oper. Margin14.70% RSI (14)56.34 Volatility1.62% 1.15%
OptionableYes Debt/Eq1.56 EPS Q/Q-26.60% Profit Margin12.00% Rel Volume1.93 Prev Close37.47
ShortableYes LT Debt/Eq1.22 EarningsNov 08 BMO Payout128.10% Avg Volume4.02M Price39.08
Recom1.60 SMA201.52% SMA501.79% SMA2007.70% Volume7,622,395 Change4.30%
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Oct-16-18 03:48PM  AstraZeneca's (AZN) Lynparza Gets Another Orphan Drug Status Zacks
Oct-15-18 03:57PM  May says Irish backstop can't derail deadlocked Brexit talks Reuters
12:18PM  AstraZeneca will keep UK investment freeze if no Brexit clarity Reuters
12:04PM  AstraZeneca will keep UK investment freeze if no Brexit clarity Reuters
10:10AM  AstraZeneca halts UK investments due to Brexit uncertainties The Telegraph
09:46AM  AstraZeneca halts UK investments due to Brexit uncertainties - Le Monde Reuters
09:32AM  Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit Reuters
Oct-12-18 10:12AM  3 Large-Cap Pharma Stocks Performing Better Than Industry Zacks
10:04AM  J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion Zacks
Oct-11-18 05:16PM  Merrimack (MACK) Focuses on Early Stage Pipeline and Cost Cuts Zacks
09:01AM  3 Dividend Stocks That Pay You Better Than Pepsi Does Motley Fool
Oct-09-18 02:34PM  Top Research Reports for JPMorgan, American Express & FedEx Zacks
Oct-03-18 12:20AM  [$$] Nobel chemistry prize given for work that harnessed evolution Financial Times
Oct-02-18 11:00AM  2 Stocks That Can Safely Double Your Money Motley Fool
Oct-01-18 02:56PM  Roche Gets FDA Approval for New Formulation of Asthma Drug Zacks
Sep-28-18 10:07AM  Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs Zacks
08:00AM  Report: Developing Opportunities within AstraZeneca, Manulife Financial, Infosys, Novartis AG, Black Hills, and Shell Midstream Partners Future Expectations, Projections Moving into 2018 GlobeNewswire
03:16AM  Did AstraZeneca PLC (LON:AZN) Create Value For Shareholders? Simply Wall St.
Sep-27-18 03:10PM  Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA Zacks
Sep-26-18 10:26AM  Company News For Sep 26, 2018 Zacks
Sep-25-18 10:23AM  AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer Zacks
08:22AM  IMFINZI® (durvalumab) is the First Immunotherapy to Demonstrate Significant Overall Survival Benefit in Unresectable, Stage III Lung Cancer Business Wire
07:00AM  AstraZeneca Ships FLUMIST® QUADRIVALENT Vaccine in the US for 2018-2019 Flu Season Business Wire
Sep-24-18 10:08PM  [$$] AstraZeneca Imfinzi scores lung cancer success Financial Times
11:32AM  EU approves AstraZeneca immunotherapy drug for lung cancer Reuters
10:19AM  AstraZeneca's Diabetes Treatment Reduces Cardiovascular Risk Zacks
07:00AM  FARXIGA Achieved a Positive Result in the Phase III DECLARE-TIMI 58 Trial, a Large Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes Business Wire
06:30AM  FOCUS-As China builds biotech sector, cash floods U.S. startups Reuters
06:24AM  AstraZeneca diabetes drug cuts heart risks in major study Reuters
02:50AM  AstraZeneca diabetes drug cuts heart risks in major study Reuters
12:26AM  Focus: As China builds biotech sector, cash floods U.S. startups Reuters
Sep-23-18 09:05PM  As China builds biotech sector, cash floods U.S. startups Reuters
08:00PM  FOCUS-As China builds biotech sector, cash floods U.S. startups Reuters
01:24AM  AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times Reuters
Sep-22-18 08:04PM  AstraZeneca ceo warns of medicine shortages after Brexit - Sunday Times Reuters
06:32PM  AstraZeneca ceo warns of medicine shortages after Brexit: Sunday Times Reuters
07:15AM  3 High-Yield Stocks at Rock-Bottom Prices Motley Fool
Sep-21-18 09:30AM  NVS vs. AZN: Which Stock Is the Better Value Option? Zacks
Sep-20-18 10:54AM  Merck or Pfizer: Which is the Better Large-Cap Pharma Stock? Zacks
Sep-19-18 07:00PM  FOCUS-AstraZeneca plots China robot offensive to counter price cuts Reuters
10:46AM  AstraZeneca's Fasenra Long-Term Asthma Study Data Positive Zacks
03:02AM  Focus: AstraZeneca plots China robot offensive to counter price cuts Reuters
02:03AM  AstraZeneca plots China robot offensive to counter price cuts Reuters
01:08AM  AstraZeneca plots China robot offensive to counter price cuts Reuters
Sep-18-18 08:13AM  Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? Zacks
07:00AM  FASENRA (benralizumab) Shows Consistent Safety and Sustained Efficacy in Long-Term Phase III BORA Trial in Severe Eosinophilic Asthma Business Wire
Sep-17-18 12:06PM  AstraZeneca-Backed ADC Therapeutics Weighs IPO, Sale Bloomberg
Sep-14-18 10:02AM  Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus Zacks
09:27AM  AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia Zacks
Sep-13-18 04:14PM  US FDA Approves LUMOXITI (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia Business Wire
02:34PM  FDA approves AstraZeneca's drug for rare form of blood cancer Reuters
09:13AM  Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study Zacks
08:45AM  3 Lung Cancer Stocks That Could End September on a High Note Motley Fool
Sep-12-18 11:25AM  The Outlook for AstraZeneca Is Positive, But Its Too Early to Pull the Trigger InvestorPlace
09:45AM  Immunotherapy for NSCLC: 4 Large-Cap Pharma Stocks in Focus Zacks
Sep-10-18 08:04AM  The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson Zacks
Sep-07-18 10:41AM  Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus Zacks
10:21AM  AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status Zacks
07:55AM  The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Wallet, Advaxis Offering Benzinga
05:24AM  Does AstraZeneca PLCs (LON:AZN) Debt Level Pose A Problem? Simply Wall St.
04:55AM  AstraZeneca gets FDA breakthrough therapy label for asthma treatment Reuters
02:46AM  AstraZeneca gets FDA breakthrough therapy label for asthma treatment Reuters
02:00AM  Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype PR Newswire
Sep-05-18 04:17PM  This Biotech Got A Bullish Pop On Its Experimental Cancer Regimen Investor's Business Daily
08:00AM  PhaseBio Secures $34 Million in Series D Financing GlobeNewswire
Sep-04-18 10:08AM  AstraZeneca Up This Year So Far on Favorable Pipeline Updates Zacks
Sep-03-18 09:40AM  AstraZeneca's Lupus Drug Misses Primary Endpoint in Study Zacks
Aug-31-18 11:21AM  AstraZeneca's lupus drug fails in late-stage testing American City Business Journals
08:39AM  4 Large Cap Pharma Stocks in Focus on Robust Cancer Pipeline Zacks
02:22AM  AstraZeneca's Lupus Treatment Misses Goal in Final-Stage Study Bloomberg
02:22AM  AstraZeneca's Lupus Therapy Misses Goal in Late-Stage Study Bloomberg
Aug-30-18 10:39AM  AstraZeneca (AZN) Gets EU Nod for New Formulation of Bydureon Zacks
Aug-27-18 04:01PM  Bausch (BHC) Gets FDA Approval for Altreno for Acne Vulgaris Zacks
02:00PM  AstraZeneca files suit against Durham generic drug maker American City Business Journals
09:38AM  AbbVie's Rare Blood Cancer Drug Combo Snags FDA Approval Benzinga
Aug-24-18 02:57PM  Chinas Pharma Boom Harvest Exchange
09:40AM  AstraZeneca's Bevespi Unimpressive in Phase III COPD Study Zacks
08:54AM  Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs Zacks
Aug-23-18 03:03AM  AstraZeneca inhaler lags GSK drug in lung disease trial Reuters
Aug-22-18 11:26AM  AstraZeneca switches contractor as new headquarter delayed again Reuters
11:14AM  AstraZeneca switches contractor as new HQ delayed again Reuters
Aug-21-18 05:38PM  Japan Nods to AstraZeneca's Tagrisso for First-Line NSCLC Zacks
Aug-20-18 12:45PM  CEMI: Ethiopian Tender, Bio-Manguinhos Order Propel Q2 Product Sales. More Revenue Catalysts Emerge. Zacks Small Cap Research
Aug-17-18 10:54AM  Top Research Reports for Cisco, AstraZeneca & Enbridge Zacks
Aug-16-18 11:05AM  Jefferies Downgrades AstraZeneca, Sees Limited Additional Upside Benzinga
Aug-15-18 04:20AM  [$$] European Corporate Roundup for Wednesday The Wall Street Journal
Aug-13-18 02:52PM  Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech Benzinga
07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
Aug-08-18 03:36AM  AstraZeneca settles Texas drug lawsuits for $110 mln Reuters
Aug-07-18 04:44PM  AstraZeneca to Pay $110 Million to Settle Texas Drug Suits Bloomberg
10:24AM  Ironwood (IRWD) Q2 Earnings & Revenues Miss, Shares Down Zacks
Aug-03-18 04:09PM  Tesaro CEO Says Its Drug 'Will Get There' Analysts Strongly Disagree Investor's Business Daily
Aug-02-18 07:01PM  To Get the Latest Drugs, Head to China Bloomberg
Aug-01-18 05:24PM  The opioid drug that addicts don't like could be approved next spring American City Business Journals
Jul-30-18 09:49AM  Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT Zacks
03:18AM  Edited Transcript of AZN.L earnings conference call or presentation 26-Jul-18 11:30am GMT Thomson Reuters StreetEvents
Jul-27-18 11:43AM  Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod Zacks
08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga
08:33AM  AstraZeneca's key lung cancer drug wins European panel thumbs-up Reuters
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics; and with Biothera Pharmaceuticals, Inc. to evaluate cancer related drugs. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerSep 28Buy15.00246,6663,699,9902,164,855Oct 02 09:35 PM